Ji Wan Qiu

Ji Wan Qiu

Chief Executive Officer at QYUNS THERAPEUTICS CO., LTD.

Net worth: 206 M $ as of 2024-04-29

52 year
Health Technology
Consumer Services

Profile

Ji Wan Qiu is the Chairman & Chief Executive Officer of Qyuns Therapeutics Co., Ltd., a company founded in 2015.
He was also the General Manager of Jiangsu T-Mab Biopharma Co. Ltd., a company founded in 2005.
Mr. Qiu previously held the position of Director-Research Institute at Hangzhou Jiuyuan Gene Engineering Co. Ltd.
from 1993 to 2004.
He was also the Deputy General Manager at Epitomics (Hangzhou) Biotechnology Co., Ltd.
from 2004 to 2005.
Additionally, Mr. Qiu served as the General Manager of Jiangsu Cellularforce Biotechnology Co. Ltd.
from 2018 to 2023.
Mr. Qiu obtained an MBA from Zhejiang University in 2005 and an undergraduate degree from Fudan University in 1993.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-19 70,550,000 ( 34.46% ) 206 M $ 2024-04-29

Ji Wan Qiu active positions

CompaniesPositionStart
QYUNS THERAPEUTICS CO., LTD. Chief Executive Officer 2015-06-04
All active positions of Ji Wan Qiu

Former positions of Ji Wan Qiu

CompaniesPositionEnd
Jiangsu Cellularforce Biotechnology Co. Ltd. Chief Executive Officer 2023-02-28
Jiangsu T-Mab Biopharma Co. Ltd. Chief Executive Officer 2014-12-31
Corporate Officer/Principal 2005-05-31
Corporate Officer/Principal 2003-12-31
See the detail of Ji Wan Qiu's experience

Training of Ji Wan Qiu

Fudan University Undergraduate Degree
Zhejiang University Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ji Wan Qiu's experience

Connections

98

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
QYUNS THERAPEUTICS CO., LTD.

Health Technology

Private companies4

Health Technology

Jiangsu T-Mab Biopharma Co. Ltd.

Health Technology

Jiangsu Cellularforce Biotechnology Co. Ltd.

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW